Literature DB >> 6999116

Reduction of amphotericin resistance in stationary phase cultures of Candida albicans by treatment with enzymes.

E F Gale, J Ingram, D Kerridge, V Notario, F Wayman.   

Abstract

The resistance of Candida albicans to amphotericin B methyl ester increases rapidly as cultures enter the stationary phase of growth; organisms harvested after several days in the stationary phase may have a resistance two or three orders of magnitude greater than that of exponentially growing organisms. This resistance is decreased by incubation of the organisms with enzymes which attack components of the cell wall. Of the enzymes tested, (1 leads to 3)-beta-D-glucanases are the most effective; incubation of 7 d batch cultures with exo-(1 leads to 3)-beta-D-glucanase at a concentration of 10 microgram enzyme protein (mg dry wt organisms)-1 for 24 h at 37 degrees C and pH 6.5 reduces the resistance of the organisms to a value approximating to that of exponentially growing organisms. Resistance is also decreased by treatment with chitinase, lipase, trypsin, alpha-mannosidase and (1 leads to 6)-beta-D-glucanases but, on a specific activity basis, none of these enzymes is as effective as (1 leads to 3)-beta-D-glucanase. The action of (1 leads to 3)-beta-D-glucanase is markedly enhanced by the addition during incubation of chitinase, trypsin or lipase.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6999116     DOI: 10.1099/00221287-117-2-383

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  8 in total

1.  Assessment of the effect of amphotericin B on the vitality of Candida albicans.

Authors:  R S Liao; R P Rennie; J A Talbot
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Cell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the Host.

Authors:  Ana C Mesa-Arango; Cristina Rueda; Elvira Román; Jessica Quintin; María C Terrón; Daniel Luque; Mihai G Netea; Jesus Pla; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

3.  High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance.

Authors:  S A Yoon; J A Vazquez; P E Steffan; J D Sobel; R A Akins
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

4.  Putative role of beta-1,3 glucans in Candida albicans biofilm resistance.

Authors:  Jeniel Nett; Leslie Lincoln; Karen Marchillo; Randall Massey; Kathleen Holoyda; Brian Hoff; Michelle VanHandel; David Andes
Journal:  Antimicrob Agents Chemother       Date:  2006-11-27       Impact factor: 5.191

5.  In vitro interaction between amphotericin B and azoles in Candida albicans.

Authors:  J A Vazquez; M T Arganoza; J K Vaishampayan; R A Akins
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

Review 6.  Drug resistance in human pathogenic fungi.

Authors:  K Iwata
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 7.  Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections.

Authors:  Francelise B Cavassin; João Luiz Baú-Carneiro; Rogério R Vilas-Boas; Flávio Queiroz-Telles
Journal:  Infect Dis Ther       Date:  2021-02-01

8.  Polarization-sensitive stimulated Raman scattering imaging resolves amphotericin B orientation in Candida membrane.

Authors:  Pu-Ting Dong; Cheng Zong; Zeina Dagher; Jie Hui; Junjie Li; Yuewei Zhan; Meng Zhang; Michael K Mansour; Ji-Xin Cheng
Journal:  Sci Adv       Date:  2021-01-06       Impact factor: 14.136

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.